CannabisNewsBreaks

MondayAug 23, 2021 12:23 pm

CBDNewsBreaks – Why Flora Growth Corp. (NASDAQ: FLGC) Is ‘One to Watch’

Flora Growth Corp. (NASDAQ: FLGC), an internationally focused cannabis brand builder, boasts a portfolio that spans several verticals, including pharmaceuticals, textiles, cosmetics, and food and beverage — each with a thoughtful brand designed to resonate with its intended end customer. From Flora Lab SAS and Flora Beauty to KASA Wholefoods and Hemp Textiles & Co., each of its brands prioritizes natural ingredients and value-chain sustainability, consistent with its mission. Though the company is currently organically growing market share for its existing brand portfolio, it is also seeking revenue-generating acquisitions that offer an accretive distribution network to amplify growth. As such,…

Continue Reading

FridayAug 20, 2021 1:21 pm

CBDNewsBreaks – Red White & Bloom Brands Inc. (CSE: RWB) (OTCQX: RWBYF) Announces Progress That Tells of the Dawn of Exciting Times

Red White & Bloom Brands’ (CSE: RWB) (OTCQX: RWBYF) CEO Brad Rogers, in a statement contained in the company’s investor deck presentation, observed that multiple deals, “judiciously purchased and diligently structured,” were coming together to create “the most exciting times in the history of the company.” Rogers further noted that the company was focused on building its key assets and growing the bottom line for its shareholders. “Red White & Bloom recently made two announcements that show its progress thus far and perhaps tell of the dawn of the exciting times. On July 22, the company announced its Q4 2020…

Continue Reading

ThursdayAug 19, 2021 12:56 pm

CBDNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM), BayMedica Collaborate to Build Leading Rare Cannabinoid Company

InMed Pharmaceuticals (NASDAQ: INM) is a clinical-stage company developing cannabinoid-based pharmaceutical drug candidates and manufacturing technologies for pharmaceutical-grade rare cannabinoids. The company is creating a pipeline of drug candidates to treat various diseases with high unmet medical needs. “In a move to grow its market presence and strengthen its operations, the company announced that it had entered into a non-binding letter of intent (“LOI”) to acquire BayMedica Inc.,” reads a recent article. “This announcement followed the two parties’ reciprocal research collaboration agreement back in November 2020, which saw them collaborate on several projects since. The agreement allowed BayMedica to assess…

Continue Reading

ThursdayAug 19, 2021 12:39 pm

CBDNewsBreaks – Grapefruit USA Inc. (GPFT) Targeting Q3 2021 Entry into Canada for Innovative Hourglass(TM) Cream

Grapefruit USA (OTCQB: GPFT) recently announced an agreement with 6PAK Solutions Inc., a well-respected Canadian cannabis manufacturer and arm of ATG Pharma Inc. The agreement set the wheels in motion for targeted entry into Canada for its patented Hourglass(TM) Time Release THC+CBD Delivery Topical Relief Cream, one of the most effective cannabis topical creams on the market. A recent article reads, “According to the agreement, GPFT will file a Notice of New Cannabis Product (‘NNCP’) with Health Canada; the NNCP outlines the Hourglass production process including the integration of Grapefruit’s patented Z-Pod Xerogel Silica Gel technology into the Hourglass topical…

Continue Reading

FridayAug 13, 2021 2:51 pm

CBDNewsBreaks – Lexaria Bioscience Corp.’s (NASDAQ: LEXX) DehydraTECH Provides Potential for Significant Cost Savings to Health Care System

Lexaria Bioscience Corp. (NASDAQ: LEXX) recently announced the results of its antiviral drug molecular characterization study performed by the National Research Council (“NRC”). The results confirmed that the drugs tested remained stable and did not undergo changes in chemical structure when processed with DehydraTECH. “This could preserve the ability of this drug delivery platform to qualify for accelerated regulatory filings with the Food and Drug Administration (‘FDA’) in the United States plus regulators elsewhere in the world,” reads a recent article. “The potential for more rapid market authorization of DehydraTECH provides the potential for cost savings to the health care…

Continue Reading

FridayAug 13, 2021 2:34 pm

CBDNewsBreaks – RYAH Group Inc.’s (CSE: RYAH) State-of-the-Art IoT Products Provide Holistic View for Optimal Research

RYAH Group (CSE: RYAH), a connected device and big data and technology company, is standing by to provide a wealth of smart devices, artificial intelligence and an integrated platform that will fully support the U.S. as it explores the benefits, risks and effects of cannabis. “U.S. researchers can benefit from RYAH Group’s state-of-the-art IoT suite of products. The technology collects, analyzes and leverages objective data throughout the research process. As a result, the company boasts one of the largest plant-based medicine databases globally with 200,000 plus registered users. The company’s ecosystem of products allows data to be collected from seed…

Continue Reading

WednesdayAug 11, 2021 2:27 pm

CBDNewsBreaks – Golden Triangle Ventures Inc. (GTVH), HyFrontier Technologies Duplicating Thunderstorm-Induced Enhanced Plant Growth

Golden Triangle Ventures (OTC: GTVH) and its newly acquired wholly owned subsidiary, HyFrontier Technologies, are working together to offer HyGro, a patent-pending, first-of-its-kind hydrogen and oxygen delivery system for agriculture developed to improve global crop-production efficiency. According to a recent article, HyGro is “based on the understanding that lighting and thunderstorms deliver nitrogen and hydrogen to the soil, resulting in enhanced growth. In-house testing shows that hydrogen is capable of increasing crop yields by up to 25% and, in many circumstances, much higher. ‘A bolt of lightning is so powerful, it breaks the covalent bonds of both the air and…

Continue Reading

TuesdayAug 10, 2021 3:22 pm

CBDNewsBreaks – Grapefruit USA Inc.’s (GPFT) Hourglass Stands Distinct in the Market

Grapefruit USA (OTCQB: GPFT) holds permits and licenses to both manufacture and distribute cannabis products throughout the state of California. “Grapefruit’s flagship product — Hourglass time-release delivery cream — features cutting-edge science and technology that solve the age-old problem of THC and other cannabinoids not being easily absorbed through the skin,” reads a recent article discussing the company and its innovative product. “The topical cream uses patented microsized particles to slowly deliver THC and a wide range of cannabinoids through skin topical administration. No other topical cream product on the market provides users with the holistic benefits of the range…

Continue Reading

FridayAug 06, 2021 2:00 pm

CBDNewsBreaks – Lexaria Bioscience Corp. (NASDAQ: LEXX) Well Positioned to Advance Business, Further Execute on Drug-Delivery Goals

Lexaria Bioscience Corp. (NASDAQ: LEXX) is constantly collaborating with research institutions and businesses to identify new ways to innovate and improve its DehydraTECH(TM) drug-delivery technology. DehydraTECH is already being monetized through commercial use, and the company is utilizing advanced 2.0 formulations in ongoing human studies. A recent article discusses Lexaria’s move to consolidate the trading of its shares solely on the Nasdaq, and resulting advantages to the company and its shareholders. “Since it was listed back in January 2021, a substantial fraction of its shareholders moved onto this exchange. To them, it offered more liquidity than ever before, and to…

Continue Reading

FridayAug 06, 2021 1:45 pm

CBDNewsBreaks – RYAH Group Inc. (CSE: RYAH) Paving Way for Better Outcomes of Plant-Based Treatments

RYAH Group (CSE: RYAH), a connected device and big data and technology company, is known for its high-quality information and digital health care analytics through which it is positively impacting the future treatment of patients for various medical conditions worldwide. RYAH is partnering with the University of Milan and companies like Medical Kiwi to drive innovation and deliver cutting-edge medical solutions, as well as providing the necessary dose-measuring devices to an oncology clinic in the U.K. “RYAH Group is paving the way for a better understanding and better outcomes of plant-based treatments globally,” reads a recent article. “This is achieved…

Continue Reading